Showing 1 - 7 results of 7 for search 'Tobias A W Holderried', query time: 0.04s
Refine Results
-
1
The Role of Immune Checkpoints after Cellular Therapy by Friederike Schmitz, Dominik Wolf, Tobias A.W. Holderried
Published 2020-05-01
Article -
2
Preliminary Report for the Development of a Multiparameter Protocol for the Identification of Sinusoidal Obstruction Syndrome including Abdominal Ultrasound before and after Alloge... by Sebastian Schlaweck, Claus Juergen Bauer, Friederike Schmitz, Peter Brossart, Tobias A. W. Holderried, Valentin Sebastian Schäfer
Published 2022-01-01
Article -
3
-
4
Peripheral blood kinetics following total body irradiation and allogeneic hematopoietic stem cell transplantation: Timing matters by Cas S. Dejonckheere, Alexander M. C. Böhner, Eva Schmitz, Tobias A. W. Holderried, Leonard C. Schmeel, Peter Brossart, Frank A. Giordano, Mümtaz A. Köksal
Published 2023-03-01
Article -
5
Hospital sanitary facilities on wards with high antibiotic exposure play an important role in maintaining a reservoir of resistant pathogens, even over many years by Claudio Neidhöfer, Esther Sib, Marcel Neuenhoff, Oliver Schwengers, Tobias Dummin, Christian Buechler, Niklas Klein, Julian Balks, Katharina Axtmann, Katjana Schwab, Tobias A. W. Holderried, Georg Feldmann, Peter Brossart, Steffen Engelhart, Nico T. Mutters, Gabriele Bierbaum, Marijo Parčina
Published 2023-04-01
Article -
6
NK Cells Regulate CD8+ T Cell Mediated Autoimmunity by Philipp A. Lang, Philipp A. Lang, Philipp A. Lang, Sarah Q. Crome, Sarah Q. Crome, Haifeng C. Xu, Haifeng C. Xu, Karl S. Lang, Karl S. Lang, Laurence Chapatte, Elissa K. Deenick, Elissa K. Deenick, Melanie Grusdat, Aleksandra A. Pandyra, Vitaly I. Pozdeev, Ruifeng Wang, Tobias A. W. Holderried, Tobias A. W. Holderried, Harvey Cantor, Andreas Diefenbach, Andreas Diefenbach, Andreas Diefenbach, Alisha R. Elford, David R. McIlwain, Mike Recher, Dieter Häussinger, Tak W. Mak, Tak W. Mak, Pamela S. Ohashi, Pamela S. Ohashi
Published 2020-02-01
Article -
7
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia by Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, Matthias Stelljes, Verena Gaidzik, Michael Lauseker, Oliver Kriege, Mareike Verbeek, Julia Marie Unglaub, Felicitas Thol, Stefan W. Krause, Mathias Hänel, Charlotte Neuerburg, Vladan Vucinic, Christian-Friedrich Jehn, Julia Severmann, Maxi Wass, Lars Fransecky, Jens Chemnitz, Udo Holtick, Kerstin Schäfer-Eckart, Josephine Schröder, Sabrina Kraus, William Krüger, Ulrich Kaiser, Sebastian Scholl, Kathrin Koch, Lea Henning, Guido Kobbe, Rainer Haas, Nael Alakel, Maximilian-Alexander Röhnert, Katja Sockel, Maher Hanoun, Uwe Platzbecker, Tobias A. W. Holderried, Anke Morgner, Michael Heuser, Tim Sauer, Katharina S. Götze, Eva Wagner-Drouet, Konstanze Döhner, Hartmut Döhner, Christoph Schliemann, Johannes Schetelig, Martin Bornhäuser, Ulrich Germing, Thomas Schroeder, Jan Moritz Middeke
Published 2021-10-01
Article